In Osteoarthritis Osteoarthritis is a condition that causes pain and stiffness in the joints. Hyaluron 200mg Tablet helps relieve pain and reduces inflammation and swelling in your joints due to this condition. This will ensure that you have a better, more active, quality of life. Additionally, you may consider simple lifestyle modifications such as regular exercise, losing weight, maintaining good posture while doing various daily activities, and wearing comfortable footwear. This will help you manage mild symptoms of osteoarthritis very effectively in the long run.
Consuming alcohol with Hyaluron 200mg Tablet does not cause any harmful side effects.
Hyaluron 200mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Hyaluron 200mg Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Hyaluron 200mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Hyaluron 200mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Hyaluron 200mg Tablet may not be needed in these patients. Please consult your doctor.
Hyaluron 200mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Hyaluron 200mg Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Hyaluron 200mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More